Revolutionizing Diabetes Care: Discover the Future of Continuous Glucose Monitoring 💡🩺

Don’t miss this exclusive opportunity to explore a groundbreaking innovation that could reshape how diabetes is managed. Join us for an inside look at Glucotrack (NASDAQ: GCTK) a cutting-edge medical technology company pushing the boundaries of continuous glucose monitoring (CGM). Glucotrack is developing a fully implantable, investigational Continuous Blood Glucose Monitor (CBGM)—a next-generation system designed to measure glucose directly from the blood, without any on-body components, and with the potential to last up to three years. Fresh off successful first-in-human trials, this webinar will dive into the science, the breakthrough results, and what lies ahead for this novel approach to glucose monitoring. 🔍 What You’ll Learn: • How CBGM technology works—and how it could transform life for people with diabetes • The critical role of real-time, continuous blood glucose tracking • Why the current CGM landscape needs a bold new solution • Highlights from Glucotrack’s first-in-human clinical trial • What’s next: details on the newly announced long-term clinical study 📅 Join leading experts and company insiders to get a first-hand look at a technology that could change the game for millions living with diabetes. ------------------------------------------------------------------------------------ 🌟 Explore More From Benzinga: 📈 Financial News & Insights // https://www.benzinga.com/ 📰 Real-Time News Headlines // https://www.benzinga.com/pro/ 📊 Market & Alternative Data APIs // https://www.benzinga.com/apis/ 🌐 Conferences & Events // https://www.benzinga.com/events/ 📢 Disclaimer: Trading in financial markets involves significant risk, and there is no guarantee of profit. The information provided by any financial product or service is for educational purposes and should not be considered as financial advice. Before making any investment decisions, it's important to conduct thorough research and consult with a qualified financial advisor. Past performance is not indicative of future results. Always invest what you can afford to lose and be aware of the potential for loss in any investment strategy. #Benzinga #Glucotrack #Webinar